Ignite Creation Date:
2024-05-06 @ 5:03 PM
Last Modification Date:
2024-10-26 @ 2:21 PM
Study NCT ID:
NCT05174650
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-05-23
First Post:
2021-11-09
Brief Title:
Treatment of Atezolizumab and Derazantinib in Patients With Advanced iCCA With FGFR2 FusionsRearrangements
Sponsor:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Organization:
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-04-20
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-08
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-09
First Submit QC Date:
December 13 2021
Study First Post Date:
2022-01-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-22
Last Update Post Date:
2023-05-23
Last Update Post Date Type:
ACTUAL